SCOTTO & ASSOCIÉS is providing tax advice to the Bio-Access group and its shareholders in connection with the acquisition of the company by Eurofins
Paris, June 22, 2015
Bio-Access is a French group of clinical laboratories with a presence in various regions of France and more than 100 laboratories. It employs approximately 1,100 people in its laboratories and is expected to generate revenue of approximately 140 million euros in 2015.
The founder and majority shareholder of Bio-Access, Mr. Jean-Louis Oger, announced on June 17, 2015, that he, along with his shareholders and senior executives, had entered into an agreement with Eurofins Scientific (the world’s leading provider in the bioanalytics market) to transfer control of the group. Several current Bio-Access shareholders—including biologists and senior executives—will co-invest alongside Eurofins and Mr. Jean-Louis Oger.
The transaction, which will enable Bio-Access to strengthen and expand its network in France, is expected to be finalized in the coming months.
Scotto & Associés provides tax advisory services to the Bio-Access Group and its shareholders, in coordination with CMS Francis Lefebvre (Lyon). Mayer Brown is handling the legal aspects.
Eurofins Scientific is advised by the law firms Racine and Avodire.
